表纸
市场调查报告书

中东、北非 (MENA) 的生命科学产业的展望、预测 (~2020年)

Middle East and North Africa (MENA) Life Sciences Industry Outlook, Forecast to 2020

出版商 Frost & Sullivan 商品编码 910105
出版日期 内容资讯 英文 42 Pages
商品交期: 最快1-2个工作天内
价格
Back to Top
中东、北非 (MENA) 的生命科学产业的展望、预测 (~2020年) Middle East and North Africa (MENA) Life Sciences Industry Outlook, Forecast to 2020
出版日期: 2019年08月23日内容资讯: 英文 42 Pages
简介

现场制造的扩大及对文明病的政府支出的增加,预计成为2020年主要的市场成长的推动要素。中东、北非 (MENA) 的生命科学市场规模,预计至2020年超过400亿美元。

本报告提供中东、北非 (MENA) 的生命科学产业的相关调查,市场概要与预测,收益预测,各市场区隔的预测,主要趋势与成长机会,策略性建议和未来展望等相关汇整。

摘要整理

MENA的生命科学市场主要预测

  • 预测1:医药品制造的本土化
  • 预测2:NGS实验的认识、引进的扩大
  • 预测3:中东的糖尿病和对其他文明病的预算上升

各国的预测

  • KSA (沙乌地阿拉伯)
  • UAE (阿拉伯联合大公国)
  • 科威特
  • 埃及
  • 阿尔及利亚
  • 摩洛哥

医药品、生物科技部门的展望

  • 市场概要
  • 主要的成长机会
  • 关注企业

IVD部门的展望

  • 市场概要
  • 主要的成长机会
  • 关注企业

结论

附录

关于Frost&Sullivan

目录
Product Code: PA76-52

Increased Local Manufacturing and Government Spending on Lifestyle Diseases to be Key Driving Factors in 2020

In this research deliverable, Frost & Sullivan's analyst team provides bold perspectives and predictions for the Middle East and North Africa (MENA) region's life sciences industry in 2020. The markets covered include pharmaceuticals, biotechnology, and in-vitro diagnostics. The analysis captures the impact of trends that are expected to transpire over 2019 and 2020 as organizations prepare for the future. This study provides guidance on where to find the greatest opportunities for expansion and which key companies to look out for.

Frost & Sullivan projects the MENA Life Sciences market to cross US$ 40 billion by 2020. A shift in the focus of healthcare towards lifestyle-driven chronic health conditions and an increasingly affluent population's preference for research-based branded drugs and preventive screening diagnostic tests are expected to drive the MENA life sciences market during the forecast period (2019 to 2020). Ongoing economic diversification and localization efforts by governments will make the domestic production of branded generic drugs more important than ever for both local consumption and export services. In addition, the regulatory environment will see a major transformation in each country. Given the on-going localization trends, it will be critical for global pharma MNCs to strategically collaborate with local agents or CMOs for their expertise on domestic contacts, customs regulations, and faster time to market in the MENA region. Areas exhibiting high growth opportunities will be the main focus of governments and industries alike. Business models specific to MENA will be pursued in contrast to those in larger markets of developed nations. Mergers and acquisitions are expected as stakeholders collaborate to achieve common outcomes. The outlook foresees increased collaboration and M&A activities between the life sciences and other healthcare sectors, in which preventative digital technology innovations will support the prevention of the onset of chronic and genetic diseases. Health spending is expected to rise in the region with governments aiming to meet sustainable development goals.

Research Highlights:

  • Market overview and projections for the MENA life sciences market in 2020
  • Revenue forecast by key MENA life sciences markets
  • Key predictions for the life sciences market in 2020 by segment
  • Key trends and growth opportunities affecting the MENA life sciences market
  • Strategic recommendations and future outlook of the life sciences market

Key Issues Addressed:

  • What are the key predictions for the 2020 MENA life sciences market?
  • What is the market projection for MENA pharmaceutical/biotechnology and IVD markets for 2020?
  • Which are the most preferred countries in MENA for the localization of future drug manufacturing activities?
  • What are key growth opportunities in the MENA pharma and IVD industry for 2020?
  • Who are the companies to watch in the MENA region for the life sciences market?
  • What policies and regulatory developments will affect your company's MENA operations in 2020?
  • What are the monetization opportunities for the life science industry as major GCC countries aim to diversify towards a service-based economy?

Table of Contents

Executive Summary

  • Key 2020 MENA Life Sciences Predictions
  • Research Scope
  • MENA Life Sciences Industry Revenue, 2018-2020
  • 2020 MENA Regional Life Sciences Perspective

Key 2020 MENA Life Sciences Market Predictions

  • Prediction 1-Localization of Pharma Manufacturing
  • Prediction 2-NGS Testing Awareness and Adoption Increases
  • Prediction 3-Rise in Middle East Budget for Diabetes and Other Lifestyle Disorders

Country Predictions 2020

  • 2020 MENA Healthcare Life Sciences Predictions-KSA
  • 2020 MENA Healthcare Predictions-UAE
  • 2020 MENA Healthcare Predictions-Kuwait
  • 2020 MENA Healthcare Predictions-Egypt
  • 2020 MENA Healthcare Predictions-Algeria
  • 2020 MENA Healthcare Predictions-Morocco

Pharmaceuticals and Biotechnology Sector Outlook 2020

  • 2020 Market Snapshot-Pharmaceuticals and Biotechnology
  • Key Growth Opportunities-Pharmaceuticals and Biotechnology
  • 2020 Companies to Watch-Pharmaceuticals and Biotechnology

IVD Sector Outlook 2020

  • 2020 Market Snapshot-IVD
  • Key Growth Opportunities-IVD
  • 2020 Companies to Watch-IVD

Concluding Thoughts

  • Concluding Thoughts
  • Legal Disclaimer

Appendix

  • Market Definitions-Pharmaceuticals and Biotechnology
  • Market Definitions-IVD
  • List of Exhibits

The Frost & Sullivan Story

  • The Frost & Sullivan Story
  • Value Proposition-Future of Your Company & Career
  • Global Perspective
  • Industry Convergence
  • 360º Research Perspective
  • Implementation Excellence
  • Our Blue Ocean Strategy
Back to Top